References
- Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke7(11), 1974–1980 (1996).
- Feldmann E, Daneault N, Kwan E et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology40(10), 1541–1545 (1990).
- Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke26(1), 14–20 (1995).
- Chimowitz MI. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch. Neurol.58(10), 1690–1692 (2001).
- Gomez CR, Orr SC. Angioplasty and stenting for primary treatment of intracranial arterial stenoses. Arch. Neurol.58(10), 1687–1690 (2001).
- The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke35(6), 1388–1392 (2004).
- The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology22(2), 106–117 (2003).
- Chimowitz MI, Kokkinos J, Strong J et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology45(8), 1488–1493 (1995).
- Millikan CH, Siekert RG, Shick RM. Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Mayo Clin. Proc.30, 116–216 (1955).
- Mohr JP, Thompson JLP, Lazar RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med.345, 1444–1451 (2001).
- Benesch CG, Chimowitz MI. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology55(4), 465–466 (2000).
- Chimowitz MI, Lynn MJ, Howlett-Smith H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med.352(13), 1305–1316 (2005).
- Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin vs. aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID. Neurology67(7), 1275–1278 (2006).
- Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol. Sci.143(1–2), 1–13 (1996).
- CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet348(9038), 1329–1339 (1996).
- Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation113(4), 555–563 (2006).
- Kwon SU, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke36(4), 782–786 (2005).
- Amarenco P, Bogousslavsky J, Callahan A 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med.355(6), 549–559 (2006).
- Schoenhagen P, Tuzcu EM, Apperson-Hansen C et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation113(24), 2826–2834 (2006).
- Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA295(13), 1556–1565 (2006).
- Sundt TM Jr, Siekert RG, Piepgras DG, Sharbrough FW, Houser OW. Bypass surgery for vascular disease of the carotid system. Mayo Clin. Proc.51(11), 677–6792 (1976).
- The EC-IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N. Engl. J. Med.313, 1191–1200 (1985).
- Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc.55(11), 673–680 (1980).
- O’Leary DH, Clouse ME. Percutaneous transluminal angioplasty of the cavernous carotid artery for recurrent ischemia. Am. J. Neuroradiol.5(5), 644–645 (1984).
- Chaloupka JC, Weigele JB, Mangla S, Lesley WS. Cerebrovascular angioplasty and stenting for the prevention of stroke. Curr. Neurol. Neurosci. Rep.1(1), 39–53 (2001).
- Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J. Neurosurg.91(3), 415–423 (1999).
- Marks MP, Wojak JC, Al-Ali F et al. Angioplasty for symptomatic intracranial stenosis. Clinical Outcome. Stroke37(4), 1016–1020 (2006).
- Gomez CR, Misra VK, Liu MW et al. Elective stenting of symptomatic basilar artery stenosis. Stroke31(1), 95–99 (2000).
- Kim DJ, Lee BH, Kim DI, Shim WH, Jeon P, Lee TH. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. Am. J. Neuroradiol.26(6), 1381–1388 (2005).
- Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. Am. J. Neuroradiol.26(4), 869–874 (2005).
- Weber W, Mayer TE, Henkes H et al. Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur. J. Radiol.55(2), 231–236 (2005).
- Jiang WJ, Wang YJ, Du B et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke35(6), 1375–1380 (2004).
- Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke36(12), E165–E168 (2005).
- Lee TH, Kim DH, Lee BH et al. Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. Am. J. Neuroradiol.26(1), 166–174 (2005).
- Yan BP, Clark DJ, Ajani AE. Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opin. Pharmacother.6(1), 3–12 (2005).
- Jaeger HJ, Mathias KD, Drescher R et al. Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain.Am. J. Neuroradiol.22(7), 1251–1259 (2001).
- Alberts MJ, Hademenos G, Latchaw RE et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA283(23), 3102–3109 (2000).
- Levy EI, Horowitz MB, Koebbe CJ et al. Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery48(6), 1215–1221 (2001).
- Kim JK, Ahn JY, Lee BH et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.J. Neurol. Neurosurg. Psychiatry75(6), 847–851 (2004).
Websites
- US Food and Drug Adminisration www.fda.gov/cdrh/pdf/h010004b.pdf
- US Food and Drug Administration www.fda.gov/cdrh/pdf5/h050001b.pdf